1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. GSK plc
  6. News
  7. Summary
    GSK   GB0009252882

GSK PLC

(GSK)
  Report
Delayed London Stock Exchange  -  11:39 2022-06-24 am EDT
1754.00 GBX   +2.00%
06/24European Stocks Join Global Rally, Closes Week in the Green
MT
06/24SECTOR UPDATE : Health Care Stocks Edge Higher Premarket Friday
MT
06/24European shares mark strong end to nervous week
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

S&P Maintains GSK's Ratings, Stable Outlook on Expected Post-Demerger Recovery

05/18/2022 | 11:24pm EDT


© MT Newswires 2022
All news about GSK PLC
06/24European Stocks Join Global Rally, Closes Week in the Green
MT
06/24SECTOR UPDATE : Health Care Stocks Edge Higher Premarket Friday
MT
06/24European shares mark strong end to nervous week
RE
06/24Sanofi, GSK variant-specific COVID shot found effective against Omicron
RE
06/24Sanofi, GSK COVID-19 Bivalent Vaccine Candidate Shows 72% Efficacy Against Omicron in P..
MT
06/24Sanofi, GSK Target COVID-19 Vaccine Availability in Late-2022 After New Positive Late-s..
MT
06/24Sanofi-GSK's COVID-19 Jab 72% Effective Against Omicron Variant in Late-stage Study
MT
06/24Sanofi says COVID-19 vaccine candidate yields positive trial data
RE
06/24GSK : Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19..
PU
06/24GSK Says Sanofi-GSK First To Report Successful Efficacy Study Against Omicron With COVI..
RE
More news
Analyst Recommendations on GSK PLC
More recommendations
Financials
Sales 2022 36 045 M 44 302 M 44 302 M
Net income 2022 5 278 M 6 487 M 6 487 M
Net Debt 2022 17 490 M 21 497 M 21 497 M
P/E ratio 2022 16,2x
Yield 2022 2,98%
Capitalization 88 868 M 109 B 109 B
EV / Sales 2022 2,95x
EV / Sales 2023 2,81x
Nbr of Employees 90 096
Free-Float 93,6%
Chart GSK PLC
Duration : Period :
GSK plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GSK PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 1 756,20 GBX
Average target price 1 868,86 GBX
Spread / Average Target 6,41%
EPS Revisions
Managers and Directors
Emma N. Walmsley Chief Executive Officer & Executive Director
Iain James Mackay Chief Financial Officer & Executive Director
Jonathan Richard Symonds Non-Executive Chairman
Hal V. Barron Executive Director & Chief Scientific Officer
Jon Ellis VP & Head-Technology Business Development
Sector and Competitors
1st jan.Capi. (M$)
GSK PLC9.17%109 224
JOHNSON & JOHNSON5.02%462 443
ELI LILLY AND COMPANY17.88%276 070
PFIZER, INC.-15.17%275 327
ABBVIE INC.12.51%260 755
ROCHE HOLDING AG-19.20%259 627